[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
Showing only X posts for non-authenticated requests. Use your API key in requests for full results.
"$SONY $MO $RPRX $MTSR $D $PUK $BHP and $DB are forming an excellent breakout setup pattern"
X Link @ChartMill 2025-10-16T02:00Z 11.2K followers, XXX engagements
"Kailera is not for sale now. They know they own the right mechanism and a drug that is very close to best selling drug in history from $LLy so they will not sell for $XX B or give out their company for cheap like $MTSR did. Metsera management knew they had bad data and nothing competitive with Lilly long term and thus sold the company. Kailera management is acting differently"
X Link @bioinvestor24 2025-10-14T21:26Z 4389 followers, XXX engagements
"$vktx $nvo $lly $pfe Obesity: Kailera raised $600M in series B (Kailera licensed GLP from its parent company Hengrui for $6B) $mtsr Metsera got bought at $7.3B $mrk Hansoh preclinical deal at $2B $AZN Eccogene's deal at $2B $RHHBY Roche bought Carmot at $2.7B Roche partnered with Zealand for $5.6B MASH: $akro Akero bought at $5.2B $etnb 89bio bought at $3.5B Boston pharma bought at $2B"
X Link @cloud_walker200 2025-10-14T13:46Z XXX followers, 1193 engagements
"Kailera was/is my candidate for next obesity BO. With todays pipe the price just went up"
X Link @ResearchPulse1 2025-10-14T13:44Z 1488 followers, 1494 engagements